Markets:

Overview

News

Currencies

International

Treasuries

Penumbra, Inc. Common Stock (NY:PEN)

332.35 +0.87 (+0.26%)

Streaming Delayed Price Updated: 1:08 PM EDT, Apr 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Penumbra, Inc. Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why IMARA Jumped Around 75%; Here Are 54 Biggest Movers From Yesterday ↗

September 08, 2022

Gainers

Via Benzinga

Penumbra Announces European Launch of RED® Reperfusion Catheters for Stroke Care

September 07, 2022

From Penumbra, Inc.

Via Business Wire

Penumbra Earnings Perspective: Return On Invested Capital ↗

August 18, 2022

Via Benzinga

Expert Ratings for Penumbra ↗

August 05, 2022

Penumbra (NYSE:PEN) has observed the following analyst ratings within the last quarter:

Via Benzinga

With Sustained Double-Digit Growth Profile, RBC Starts Coverage On This MedTech Stock ↗

July 18, 2022

Via Benzinga

Latest Data Demonstrates Penumbra System and RED® Reperfusion Catheters Effective for Broad Stroke Care

August 25, 2022

From Penumbra, Inc.

Via Business Wire

iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday ↗

August 08, 2022

U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session.

Via Benzinga

Despite Seeing Accelerated 2023 Growth, This Analyst Cut Penumbra's Price Target - Here's Why ↗

May 04, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About Penumbra ↗

May 04, 2022

Analysts have provided the following ratings for Penumbra (NYSE:PEN) within the last quarter:

Via Benzinga

Recap: Penumbra Q4 Earnings ↗

February 22, 2022

Penumbra (NYSE:PEN) reported its Q4 earnings results on Tuesday, February 22, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Penumbra...

Via Benzinga

Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday ↗

August 08, 2022

Gainers

Via Benzinga

Earnings Scheduled For February 22, 2022 ↗

February 22, 2022

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu...

Via Benzinga

Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session ↗

August 05, 2022

Gainers Assure Holdings Corp. (NASDAQ: IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday.

Via Benzinga

Earnings Outlook For Penumbra ↗

February 21, 2022

Penumbra (NYSE:PEN) is set to give its latest quarterly earnings report on Tuesday, 2022-02-22. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Penumbra: Q2 Earnings Insights ↗

August 04, 2022

Penumbra (NYSE:PEN) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Penumbra beat estimated earnings by...

Via Benzinga

Expert Ratings for Penumbra ↗

July 18, 2022

Over the past 3 months, 4 analysts have published their opinion on Penumbra (NYSE:PEN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...

Via Benzinga

JMP Analyst Names 5 Gambling Stocks To Buy On The Dip ↗

June 28, 2022

It's been a rough year so far for casino and online gambling stocks, but one firm has identified a handful of gambling stocks that investors should consider buying on the dip. The Analyst: JMP...

Via Benzinga

Penumbra's Return on Invested Capital Insights ↗

May 12, 2022

Pulled from Benzinga Pro data, Penumbra (NYSE:PEN) posted Q1 earnings of $79.00 thousand, an increase from Q4 of 100.32%. Sales dropped to $203.90 million, a 0.06% decrease between quarters.

Via Benzinga

Penumbra: Q1 Earnings Insights ↗

May 03, 2022

Penumbra (NYSE:PEN) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Penumbra missed estimated earnings by...

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 02, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Earnings Scheduled For May 3, 2022 ↗

May 03, 2022

Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 19, 2022 ↗

April 19, 2022

Upgrades

Via Benzinga

Penumbra Announces the European Launch of the Indigo® System With Lightning™ 7 and Lightning 12 Intelligent Aspiration

April 14, 2022

From Penumbra, Inc.

Via Business Wire

28 Biggest Movers From Yesterday ↗

April 12, 2022

Gainers SailPoint Technologies Holdings, Inc. (NYSE: SAIL) shares jumped 29.16% to close at $64.05 on Monday after private equity firm Thoma Bravo announced plans to acquire...

Via Benzinga

Penumbra Introduces Next Generation REAL® y-Series™, Expanding Virtual Reality Healthcare Platform

March 31, 2022

From Penumbra, Inc

Via Business Wire

Penumbra Posts Mixed Bag Q4 Results, Reports Topline Growth Of 22% ↗

February 23, 2022

Penumbra Inc (NYSE: PEN) posted Q4 FY21 revenue of $204 million, +22.2% Y/Y (up 23% in constant currency), beating the consensus of $194.30 million. Revenue from sales...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022 ↗

March 08, 2022

Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth...

Via Benzinga

Penumbra's Return on Invested Capital Insights ↗

February 23, 2022

Benzinga Pro data, Penumbra (NYSE:PEN) reported Q4 sales of $204.01 million. Earnings fell to a loss of $24.63 million, resulting in a 406.72% decrease from last quarter. In Q3,...

Via Benzinga

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

Penumbra Weighs Combination With Shockwave Medical: Bloomberg ↗

January 10, 2022

Penumbra Inc (NYSE: PEN) is exploring a potential deal with Shockwave Medical Inc (NASDAQ: SWAV), Bloomberg reported citing people with knowledge of the...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.